It may be resulted from an increased level of serum cytokines IL-6 and TNF in cancer patients, which would stimulate the liver to synthesize CRP.40,41 Therefore, CRP can be used as an index of the intestinal immune function for the prognosis of patients with colorectal cancer, and to observe the therapeutic effects of probiotics on the immune function. This evidence concerns the gene IL6 and cancer.